New combo therapy aims to stop deadly meningitis before it starts

NCT ID NCT03945448

First seen May 05, 2026 · Last updated May 05, 2026

Summary

This study tests whether giving a single, stronger dose of antifungal medicine (liposomal amphotericin) along with standard fluconazole can prevent cryptococcal meningitis in HIV-positive adults who have the fungus in their blood but no symptoms. About 356 participants in Uganda will be randomly assigned to the enhanced treatment or standard care alone. The goal is to see if the stronger treatment reduces the number of people who develop meningitis over 24 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRYPTOCOCCAL MENINGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • infectious Disease Institute Kampala,Uganda

    RECRUITING

    Kampala, Uganda

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.